Amy Buckley

686 total citations
16 papers, 533 citations indexed

About

Amy Buckley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Amy Buckley has authored 16 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Amy Buckley's work include Esophageal Cancer Research and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Inflammatory Bowel Disease (3 papers). Amy Buckley is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Inflammatory Bowel Disease (3 papers). Amy Buckley collaborates with scholars based in Ireland, United Kingdom and Canada. Amy Buckley's co-authors include Jacintha O’Sullivan, Niamh Lynam‐Lennon, Oscar Cordero Llana, Maeve A. Caldwell, James B. Uney, Nora Bengoa‐Vergniory, Michael J. O’Neill, Kirsty J. McMillan, Jane Cooper and Tracey K. Murray and has published in prestigious journals such as Gastroenterology, Nature Nanotechnology and Scientific Reports.

In The Last Decade

Amy Buckley

15 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Buckley Ireland	8	265	151	117	76	74	16	533
Yongtian Lu China	12	277 1.0×	260 1.7×	131 1.1×	108 1.4×	52 0.7×	36	641
Pei‐Yi Wu Taiwan	15	297 1.1×	129 0.9×	71 0.6×	38 0.5×	82 1.1×	26	585
Seoyeon Bok South Korea	12	242 0.9×	124 0.8×	77 0.7×	72 0.9×	119 1.6×	27	569
Yi Duan China	14	393 1.5×	138 0.9×	142 1.2×	92 1.2×	96 1.3×	39	734
Hanjiao Qin China	13	304 1.1×	98 0.6×	90 0.8×	72 0.9×	53 0.7×	23	618
Xiangyu Wang China	15	233 0.9×	178 1.2×	281 2.4×	131 1.7×	89 1.2×	43	711
Agnieszka Zimna Poland	9	341 1.3×	186 1.2×	74 0.6×	57 0.8×	100 1.4×	24	709
Xiaoli Yang China	18	393 1.5×	137 0.9×	138 1.2×	73 1.0×	45 0.6×	43	757
Weiwei Yu China	11	191 0.7×	105 0.7×	71 0.6×	56 0.7×	65 0.9×	15	434

Countries citing papers authored by Amy Buckley

Since Specialization

Citations

This map shows the geographic impact of Amy Buckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Buckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Buckley more than expected).

Fields of papers citing papers by Amy Buckley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Buckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Buckley. The network helps show where Amy Buckley may publish in the future.

Co-authorship network of co-authors of Amy Buckley

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Buckley. A scholar is included among the top collaborators of Amy Buckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Buckley. Amy Buckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bancil, Aaron, Alicia Sandall, Selina Cox, et al.. (2025). 796: A MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, RE-SUPPLEMENTATION TRIAL DEMONSTRATES THE EFFICACY OF A LOW EMULSIFIER DIET IN 154 PATIENTS WITH MILD TO MODERATELY ACTIVE CROHN’S DISEASE: THE ADDAPT TRIAL. Gastroenterology. 169(1). S–187.

O'Connell, J E A, Amy Buckley, Cara Dunne, et al.. (2022). Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis. Intestinal Research. 20(3). 381–385. 2 indexed citations

Marcone, Simone, Amy Buckley, Colm J. Ryan, et al.. (2021). Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma. Cancer Treatment and Research Communications. 27. 100376–100376. 7 indexed citations

McCready, Jessica, Margaret R. Dunne, Noel E. Donlon, et al.. (2021). Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction. Metabolites. 11(11). 768–768. 5 indexed citations

Buckley, Amy, Niamh Clarke, Noel E. Donlon, et al.. (2020). Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant model. Translational Oncology. 14(1). 100882–100882. 5 indexed citations

Buckley, Amy, et al.. (2020). Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers. Nature Reviews Gastroenterology & Hepatology. 17(5). 298–313. 194 indexed citations

Buckley, Amy, Margaret R. Dunne, Susan Kennedy, et al.. (2020). Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib. Scientific Reports. 10(1). 12105–12105. 8 indexed citations

Kennedy, Susan, Margaret R. Dunne, Fiona O’Connell, et al.. (2020). Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors. BMC Cancer. 20(1). 952–952. 2 indexed citations

Buckley, Amy, Margaret R. Dunne, Niamh Lynam‐Lennon, et al.. (2019). Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma. Cancer Letters. 447. 115–129. 17 indexed citations

10.

Buckley, Amy, B. Bibby, Margaret R. Dunne, et al.. (2019). Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals. 12(1). 33–33. 8 indexed citations

11.

O'Connell, J E A, P. F. McDonagh, Niamh Clarke, et al.. (2019). P095 Association between tissue oncostatin M expression and infliximab response in corticosteroid refractory acute severe ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S133–S134. 3 indexed citations

12.

Kennedy, Susan, Amy Buckley, Emer Conroy, et al.. (2019). 1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours. Oncotarget. 10(38). 3725–3744. 4 indexed citations

13.

Crompton, Lucy, Aman Sood, Margaret Saunders, et al.. (2018). Nanoparticle-induced neuronal toxicity across placental barriers is mediated by autophagy and dependent on astrocytes. Nature Nanotechnology. 13(5). 427–433. 112 indexed citations

14.

Buckley, Amy, et al.. (2018). Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma. Cancer and Metastasis Reviews. 37(2-3). 335–345. 26 indexed citations

15.

Buckley, Amy, Niamh Lynam‐Lennon, Susan Kennedy, et al.. (2018). Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma. Oncotarget. 9(72). 33634–33647. 20 indexed citations

16.

McMillan, Kirsty J., Tracey K. Murray, Nora Bengoa‐Vergniory, et al.. (2017). Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo. Molecular Therapy. 25(10). 2404–2414. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact